NWPF

News Archives

Filtered by: August 2003

New Drug Reduces Advanced Parkinson’s Symptoms

Thursday August 28, 2003

After 40 years of treating Parkinson’s disease with dopamine medications, a new study shows potential for a non-dopamine drug that may provide benefit for patients with advanced Parkinson’s disease.

Read Article

Gene Therapy Used to Treat Patients With Parkinson’s; FDA Approves Procedure on 12 Patients

Tuesday August 19, 2003

Yesterday at New York-Presbyterian Hospital a 55 year old man became the first person to undergo gene therapy for Parkinson’s. Despite the checkered history of gene therapy experiments, the Food and Drug Administration approved this procedure for 12 people with severe Parkinson’s.

Read Article

Parkinson’s Drug Side-Effect -- Gambling?

Tuesday August 19, 2003

The dopamine agonist Mirapex appears to have a correlation to increased addictive gambling tendencies, according to a study released by the Muhammad Ali Parkinson Research Center. The risk is small, but significant enough that doctors may be urged to raise awareness when prescribing the medication.

Read Article

Pain Relievers Might Cut PD Risk

Monday August 18, 2003

The risk of developing PD was 45 percent lower in people who used drugs such as ibuprofen and naproxen at least twice weekly than it was in nonusers, according to a review of two large studies.

Read Article
<< Back 1 - 4 of 4 Next >>

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement